help + privacy policy + contact us + links + home
 
About APhACareerse-CommunitiesMeetingsPublicationsJoin APhA
Government Affairs  

Advertisement


Advertisement


American 
Pharmacists 
Month

APhA CEO Blog

APhA 
Foundation



2010 International Pharmaceutical Federation PSWC and AAPS Annual 
Meeting

Print this page

Discuss the president's HCR proposal and express your support for pharmacist clinical services

Obama plan silent on pharmacy provisions included in House and Senate bills.

On Monday, President Obama released his health care reform proposal in preparation for his February 25 bipartisan White House Summit, which is intended to revive the stalled health care reform (HCR) discussions. This proposal is not a comprehensive health care reform bill (i.e., statutory and/or legislative language).  Rather, the Obama plan is a collection of changes to the Senate-passed Patient Protection and Affordable Care Act (H.R. 3590), which incorporates certain provisions from the House HCR bill (H.R.3962), new proposals not addressed by either chamber, and modifications to the Senate provisions. In short, Obama's proposal is framed as a targeted set of changes to the Senate bill and the changes to these provisions could ultimately be included in budget reconciliation legislation.

Reports indicate that Obama's proposal is silent on many noncontroversial issues already addressed in the House and Senate bills, such as the provisions to expand patient access to pharmacist clinical services. We won't know if medication therapy management is included in the President's proposal until we see the legislative language.

As Members of Congress and the White House continue to work on HCR, we need to continue to show our support to ensure these provisions are included and secured in the HCR bill.  We encourage you to join today's 1:45 p.m. (EST) White House discussion on the president's HCR proposal and express your support for pharmacist clinical services.

Join the chat via Facebook or at WhiteHouse.gov

Recommended Questions (Choose one):

  • Does the President's proposal recognize a clinical role for pharmacists?
  • Does the President's proposal support the inclusion of pharmacists, the medication use experts, as providers of clinical services in integrated care models, such as medical homes?
  • How does the President's proposal plan to reduce hospital readmission rates and does this plan envision the inclusion of pharmacists, the medication use experts, in transitional care activities?
  • As the 3rd largest health care profession and the profession with the expertise on the primary form of therapy - medications- are pharmacists included in workforce provisions in the President's proposal? If so, where?

Recommended Comments (Limit to one or two):

  • As the White House pursues health care reform, I urge continued support for strong polices to ensure Americans continue to enjoy access to the vital products and services offered by pharmacists.
  • Pharmacists are the most accessible providers in our health care system, and have a key role to play in improving Americans' health through preventative services, the safe and efficient delivery of prescription medications and other health care products and through counseling services which help patients take their medications most effectively.
  • Research indicates the failure to take medicines as prescribed is major problem in our health system. Poor medication adherence costs the U.S. approximately $290 billion annually, equaling 13% of total healthcare expenditures (New England Healthcare Institute, 2009). A large portion of this spending stems from avoidable and costly health complications resulting from poor adherence. These circumstances seriously undermine quality of life, quality of care and patient outcomes. Any successful healthcare reform effort must include strong steps to improve patient adherence to medication, particularly for those with chronic disease.
  • Pharmacist-provided medication therapy management improves therapeutic outcomes while reducing costly medical services, such as emergency room visits and unnecessary physician visits. In one study, for every $1 invested in MTM programs, overall healthcare costs were reduced by $12. In 2003, Congress recognized the value of MTM when it required Part D plans to offer this service under the Medicare Modernization Act (MMA). Clearly, increasing access to MTM is one important way to improve the health system.
  • Congress has recognized the importance of this issue through provisions in both the House and Senate health reform bills that encourage medication therapy management (MTM) in the treatment of chronic disease and in community health teams that support medical homes. Both the House and Senate also include a series of grant programs in their health reform bills to encourage pharmacist-provided MTM as part of coordinated care models and chronic disease initiatives. Provisions of the Senate bill would also improve the MTM benefit in Medicare Part D and establish a bonus payment for Medicare Advantage plans that promote MTM.

Thank you in advance for your efforts.

Related resources on www.pharmacist.com:

APhA Government Affairs Staff
Posted February 24, 2010, 12:05 pm EST